Experts foresee a rebound with resistance at 19,300-19,400 levels, followed by 19,500 levels in the coming session. In case the index breaks 19,200, then the correction can be seen up to the 19,000 mark
A delayed monsoon and reduced demand for acute products impacted the industry briefly, but analysts expect the sector to sustain double-digit growth figures for the year.
Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies
Eicher Motors has shown a change in the polarity at the bearish trend line which the prices respected since September 2017, this illustrates the positive undertone of the prices.